TA

Timothy A. Springer

North America, Massachusetts, United States, Cambridge

Description

Timothy A. Springer is the Founder of Institute for Protein Innovation.

Investor Profile

Timothy A. Springer has made 12 investments, with 1 in the past 12 months and 17% as lead.

Stage Focus

  • Series A (33%)
  • Series B (33%)
  • Post Ipo Equity (17%)
  • Seed (8%)
  • Series C (8%)

Country Focus

  • United States (92%)
  • Canada (8%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Therapeutics
  • Biopharma
  • Life Science
  • Pharmaceutical
  • Oncology
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Timothy A. Springer frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 3
Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 2
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 2
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 2
Schrödinger
North America, New York, United States, New York
Co-Investments: 3
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 9
ShangPharma
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Invus
North America, New York, United States, New York
Co-Investments: 3
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 2

Which angels does Timothy A. Springer often collaborate with?

CC
North America, California, United States, Los Angeles
Shared Deals: 1
TF
Europe, Ile-de-France, France, Paris
Shared Deals: 1
RG
North America, California, United States, Los Angeles
Shared Deals: 1
AW
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Timothy A. Springer?

Cartesian Therapeutics

Gaithersburg, Maryland, United States

Pioneering Potent, Safer Cell Therapy in and Beyond Oncology

BiotechnologyOncology
Post Ipo EquityJul 2, 2024
Amount Raised: $130,000,000
Seismic Therapeutic

Watertown, Massachusetts, United States

Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.

BiotechnologyHealth CareLife ScienceMedical
Series BDec 4, 2023
Amount Raised: $121,000,000
Selecta Biosciences

Watertown, Massachusetts, United States

Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.

BiopharmaBiotechnologyPharmaceutical
Post Ipo EquityNov 13, 2023
Amount Raised: $60,250,000
Prenuvo

Vancouver, British Columbia, Canada

Prenuvo offers whole body MRI screening - we provide deep insights for earlier detection.

Health CareHealth DiagnosticsMedical
Series AOct 18, 2022
Amount Raised: $70,000,000
Seismic Therapeutic

Watertown, Massachusetts, United States

Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.

BiotechnologyHealth CareLife ScienceMedical
Series AFeb 9, 2022
Amount Raised: $101,000,000
Tectonic Therapeutic

Allston, Massachusetts, United States

Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.

Biotechnology
Series AApr 15, 2021
Amount Raised: $80,000,000
Morphic Therapeutic

Waltham, Massachusetts, United States

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

BiotechnologyHealth CareMedicalTherapeutics
Series BSep 25, 2018
Amount Raised: $80,000,000
Scholar Rock

Cambridge, Massachusetts, United States

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

BiopharmaBiotechnologyMedicalTherapeutics
Series CJan 3, 2018
Amount Raised: $47,000,000
Morphic Therapeutic

Waltham, Massachusetts, United States

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

BiotechnologyHealth CareMedicalTherapeutics
Series AJun 30, 2016
Amount Raised: $51,500,000
Scholar Rock

Cambridge, Massachusetts, United States

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

BiopharmaBiotechnologyMedicalTherapeutics
Series BJan 4, 2016
Amount Raised: $36,000,000